| 1793  Elucidating the role of Campylobacter concisus–derived indole metabolites in gut inflammation and immune modulation https://www.pnas.org/doi/10.1073/pnas.2514071122
 
 1792  Identification of medication–microbiome interactions that affect gut infection
 https://www.nature.com/articles/s41586-025-09273-8
 
 1791  A defined microbial community reproduces attributes of fine flavour chocolate fermentation
 https://www.nature.com/articles/s41564-025-02077-6
 
 1790  Yeast adapts to diverse ecological niches driven by genomics and metabolic reprogramming
 https://www.pnas.org/doi/10.1073/pnas.2502044122
 
 1789  Functional amyloid proteins confer defence against predatory bacteria
 https://www.nature.com/articles/s41586-025-09204-7
 
 1788  A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker
 https://www.pnas.org/doi/10.1073/pnas.2502240122
 
 1787  Controlled colonization of the human gut with a genetically engineered microbial therapeutic
 https://www.science.org/doi/10.1126/science.adu8000
 
 1786  Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
 https://www.pnas.org/doi/10.1073/pnas.2500276122
 
 1785  The spatiotemporal distribution of human pathogens in ancient Eurasia
 https://www.nature.com/articles/s41586-025-09192-8
 
 1784  A gut sense for a microbial pattern regulates feeding
 https://www.nature.com/articles/s41586-025-09301-7
 
 
 |